Diane F Jelinek, PhD

  • 10682 Citations
  • 61 Scopus h-Index
1981 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Letter

Biological evaluation of CpG stimulation of normal human B-cells: Implications for B-cell biology and cytogenetic analysis of CLL B-cells

Wu, X., Smoley, S. A., Peterson, M. A., Walters, D. K., Arendt, B. K., Nowakowski, G. S., Van Dyke, D. L., Kay, N. E. & Jelinek, D. F., May 1 2011, In : British journal of haematology. 153, 3, p. 402-405 4 p.

Research output: Contribution to journalLetter

CLL B cells with a bimodal CD38 expression pattern: Persistence of bimodal populations despite effective therapy for B-CLL [10]

Pittner, B. T., Jelinek, D. F. & Kay, N. E., Jan 2004, In : Leukemia. 18, 1, p. 180-182 3 p.

Research output: Contribution to journalLetter

6 Scopus citations

Cytogenetic abnormalities can change during the course of the disease process in chronic lymphocytic leukemia [9]

Shanafelt, T. D., Jelinek, D., Tschumper, R., Schwager, S., Nowakowski, G., DeWald, G. W. & Kay, N. E., Jul 1 2006, In : Journal of Clinical Oncology. 24, 19, p. 3218-3219 2 p.

Research output: Contribution to journalLetter

19 Scopus citations

Genetic characterization of SF3B1 mutations in single chronic lymphocytic leukemia cells

Wu, X., Tschumper, R. C. & Jelinek, D. F., Nov 1 2013, In : Leukemia. 27, 11, p. 2264-2267 4 p.

Research output: Contribution to journalLetter

5 Scopus citations

Karyotype evolution on fluorescent in situ hybridization analysis is associated with short survival in patients with chronic lymphocytic leukemia and is related to CD49d expression

Shanafelt, T. D., Hanson, C., Dewald, G. W., Witzig, T. E., LaPlant, B., Abrahamzon, J., Jelinek, D. F. & Kay, N. E., Sep 15 2008, In : Journal of Clinical Oncology. 26, 14, p. e5-e6

Research output: Contribution to journalLetter

41 Scopus citations

Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse

Braggio, E., Kay, N. E., Vanwier, S., Tschumper, R. C., Smoley, S., Eckel-Passow, J. E., Sassoon, T., Barrett, M., Van Dyke, D. L., Byrd, J. C., Jelinek, D. F., Shanafelt, T. D. & Fonseca, R., Jul 1 2012, In : Leukemia. 26, 7, p. 1698-1701 4 p.

Research output: Contribution to journalLetter

36 Scopus citations

No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(Immuno)therapy

Baliakas, P., Mattsson, M., Hadzidimitriou, A., Minga, E., Agathangelidis, A., Sutton, L. A., Scarfo, L., Davis, Z., Yan, X. J., Plevova, K., Sandberg, Y., Vojdeman, F. J., Tzenou, T., Chu, C. C., Veronese, S., Mansouri, L., Smedby, K. E., Giudicelli, V., Nguyen-Khac, F., Panagiotidis, P. & 20 others, Juliusson, G., Anagnostopoulos, A., Lefranc, M. P., Trentin, L., Catherwood, M., Montillo, M., Niemann, C. U., Langerak, A. W., Pospisilova, S., Stavroyianni, N., Chiorazzi, N., Oscier, D., Jelinek, D. F., Shanafelt, T., Darzentas, N., Belessi, C., Davi, F., Ghia, P., Rosenquist, R. & Stamatopoulos, K., Mar 23 2018, In : Haematologica. 103, 4, p. e158-e161

Research output: Contribution to journalLetter

7 Scopus citations

Reply to 'CD49d in B-cell chronic lymphocytic leukemia: Correlated expression with CD38 and prognostic relevance' by Zucchetto et al. [7]

Pittner, B. T., Shanafelt, T. D., Kay, N. E. & Jelinek, D. F., Mar 2006, In : Leukemia. 20, 3, 1 p.

Research output: Contribution to journalLetter

Response: Cautious interpretation of assessment of AID variant activities using cells with endogenous AID expression

Wu, X. & Jelinek, D. F., Feb 19 2009, In : Blood. 113, 8, 1 p.

Research output: Contribution to journalLetter

Survival of patients with clinically identified monoclonal B-cell lymphocytosis (MBL) relative to the age-and sex-matched general population

Shanafelt, T. D., Kay, N. E., Rabe, K. G., Call, T. G., Zent, C. S., Schwager, S. M., Leis, J. F., Jelinek, D. F., Slager, S. L. & Hanson, C. A., Feb 1 2012, In : Leukemia. 26, 2, p. 373-376 4 p.

Research output: Contribution to journalLetter

14 Scopus citations

Terminal plasmocytoid differentiation of malignant B cells induced by autotumor-reactive CD4+ T cells in one case of splenic marginal zone B-cell lymphoma [2]

Ansell, S. M., Witzig, T. E., Kurtin, P. J., Sloan, J. A., Jelinek, D. F., Howell, K. G., Markovic, S. N., Habermann, T. M., Klee, G. G., Atherton, P. J. & Erlichman, C., Jan 1 2002, In : Blood. 99, 1, p. 388-390 3 p.

Research output: Contribution to journalLetter

2 Scopus citations

T helper cell activation in B-cell lymphomas [1] (multiple letters)

Bosshart, H., Ansell, S. M., Jelinek, D. F., Wettstein, P. J. & Witzig, T. E., Jun 15 2002, In : Journal of Clinical Oncology. 20, 12, p. 2904-2905 2 p.

Research output: Contribution to journalLetter

2 Scopus citations